Abzena and OBI Pharma sign licence deal for ThioBridge technology
UK-based life sciences group Abzena has signed a licensing contract and a master service and clinical supply agreement with Taiwanese biopharmaceutical company OBI Pharma to enable process development and manufacturing using ThioBridge.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news